$51.94
0.440.85%
Last update: Nov 9, 4:00 PM
Conmed Corp
CNMDNYSE
Conmed (CNMD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Conmed (CNMD) last issued guidance on October 28, 2026 for fiscal year 2026. The company guided earnings per share in the range of $4.54 - $4.61, compared to a consensus EPS estimate of $4.54. Conmed also guided revenue in the range of $1.36B - $1.37B for the period.
Compared to prior guidance, Conmed maintained its EPS outlook from a previous range of $4.48 - $4.6. On the revenue side, the company maintained its revenue forecast from a prior range of $1.36B - $1.37B.
Conmed has issued 23 guidance updates between November 15, 2022 and October 28, 2026. During this period, the company raised its outlook 6 times and lowered it 6 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.00 | $1.11 | $0.82 | $1.32 |
| Actual | $1.04 | $1.38 | $0.89 | $1.43 |
| Surprise | +4.00% | +24.3% | +8.54% | +8.33% |
| Revenue | ||||
| Estimate | $336.4M | $337.4M | $310.6M | $366.6M |
| Actual | $335.6M | $343.5M | $317.0M | $373.2M |
| Surprise | -0.24% | +1.80% | +2.07% | +1.80% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.27 | $0.96 | $1.18 | $1.12 |
| Revenue | ||||
| Consensus | $366.6M | $330.1M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 28, 2026 | $1.04 | $1.00 | 4.00 % |
| Q2 | Jul 29, 2026 | $1.38 | $1.11 | 24.3 % |
| Q1 | Apr 29, 2026 | $0.89 | $0.82 | 8.54 % |
| Q4 | Jan 28, 2026 | $1.43 | $1.32 | 8.33 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 28, 2026 | $335.56M | $336.37M | -0.24 % |
| Q2 | Jul 29, 2026 | $343.49M | $337.42M | 1.80 % |
| Q1 | Apr 29, 2026 | $317.05M | $310.61M | 2.07 % |
| Q4 | Jan 28, 2026 | $373.20M | $366.62M | 1.80 % |
